Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Rare Neurological Diseases (CRND) is a specialized clinical research and medical facility based in Atlanta, Georgia, dedicated to orphan neurological conditions. The center serves as a high-volume clinical trial site, partnering with leading biotechnology and pharmaceutical firms to advance novel therapies through various stages of clinical development. CRND is particularly recognized for its expertise in Spinal Muscular Atrophy (SMA) and Friedreich's Ataxia, offering patients access to cutting-edge treatments such as gene therapies and antisense oligonucleotides. By combining specialized patient care with rigorous scientific research, the organization plays a critical role in the development and approval of life-changing medications for rare disease communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Rare Neurological Diseases.